Empagliflozin is a substituted benzylpiperazine derivative featuring a 4-chlorophenyl ring linked via an ether to a piperazine core, which is esterified with a 3-hydroxy-4-methoxybenzoyl moiety. The molecule incorporates a tertiary amine in the piperazine ring and a meta-chloro substituent on the aromatic ring, conferring structural rigidity and hydrophobic character. As the parent drug, it exists in a single enantiomeric form with a fully defined stereochemistry at the piperazine nitrogen. This compound serves as an HPLC reference standard for quantification in pharmaceutical dosage forms.
On RequestC1COC[C@H]1OC2=CC=C(C=C2)CC3=C(C=CC(=C3)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)Cl
InChI=1S/C23H27ClO7/c24-18-6-3-14(23-22(28)21(27)20(26)19(11-25)31-23)10-15(18)9-13-1-4-16(5-2-13)30-17-7-8-29-12-17/h1-6,10,17,19-23,25-28H,7-9,11-12H2/t17-,19+,20+,21-,22+,23-/m0/s1
OBWASQILIWPZMG-QZMOQZSNSA-N